Neuberger Berman Group
BRLI

Neuberger Berman Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Neuberger Berman Group’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-245,210
Closed -$10.1M – 1652
2015
Q2 		$10.1M Sell
245,210
-8,520
-3% -$305K 0.01% 828
2015
Q1 		$8.94M Sell
253,730
-4,867
-2% -$165K 0.01% 852
2014
Q4 		$8.31M Sell
258,597
-31,322
-11% -$906K 0.01% 858
2014
Q3 		$8.13M Sell
289,919
-1,448
-0.5% -$44.1K 0.01% 871
2014
Q2 		$8.8M Buy
291,367
+233,614
+405% +$6.45M 0.01% 859
2014
Q1 		$1.6M Buy
57,753
+45,805
+383% +$1.2M ﹤0.01% 1131
2013
Q4 		$305K Buy
11,948
+260
+2% +$8.01K ﹤0.01% 1428
2013
Q3 		$349K Buy
11,688
+485
+4% +$13.5K ﹤0.01% 1378
2013
Q2 		$322K Buy
+11,203
New +$309K ﹤0.01% 1385

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Neuberger Berman Group's BRLI Position: Q3 2015 in Review

Neuberger Berman Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 245,210 shares — an estimated $10.1M sold.

Neuberger Berman Group first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $10.1M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Neuberger Berman Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Neuberger Berman Group sold 245,210 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $10.1M.
  • Neuberger Berman Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Neuberger Berman Group's BIO-REFERENCE LABS INC-NEW- position peaked at $10.1M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Neuberger Berman Group's 13F filing for Q3 2015, filed 10 Nov 2015.